Pine Valley Investments’s Revelation Biosciences Warrant REVBW Stock Holding History

Pine Valley Investments’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87K	Sell	236,857 -8,572	-3%	-$89	﹤0.01%	609
2026 Q1	$1.65K	Hold	245,429	–	–	﹤0.01%	574
2025 Q4	$1.96K	Hold	245,429	–	–	﹤0.01%	560
2025 Q3	$2.58K	Hold	245,429	–	–	﹤0.01%	562
2025 Q2	$2.95K	Hold	245,429	–	–	﹤0.01%	551
2025 Q1	$2.65K	Buy	245,429 +146,139	+147%	+$2.25K	﹤0.01%	558
2024 Q4	$695	Sell	99,290 -42,858	-30%	-$501	﹤0.01%	518
2024 Q3	$2.13K	Hold	142,148	–	–	﹤0.01%	515
2024 Q2	$2.84K	Sell	142,148 -2,858	-2%	-$47	﹤0.01%	482
2024 Q1	$3.84K	Sell	145,006 -146,139	-50%	-$2.02K	﹤0.01%	487
2023 Q4	$3.09K	Buy	291,145 +41,431	+17%	+$526	﹤0.01%	490
2023 Q3	$4.22K	Buy	249,714 +205,849	+469%	+$3.4K	﹤0.01%	466
2023 Q2	$781	Hold	43,865	–	–	﹤0.01%	425
2023 Q1	$786	Buy	+43,865	New	+$1.1K	﹤0.01%	311

Other funds holding REVBW

T3 Companies New York $93.7M AUM

SIA

Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return

QWM

Quaker Wealth Management Moorestown, New Jersey $344M AUM 15.21% 1-Year Est. Return

Pine Valley Investments's REVBW Position: Q2 2026 in Review

Pine Valley Investments reduced its Revelation Biosciences Warrant (REVBW) stake by 3.5% in Q2 2026, selling an estimated $89 and leaving 236,857 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Pine Valley Investments first reported a position in REVBW in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.22K in Q3 2023. 4 funds tracked by Wall St. Rank hold REVBW as of Q2 2026.

Pine Valley Investments held 236,857 shares of Revelation Biosciences Warrant worth $1.87K as of Q2 2026.
Pine Valley Investments sold 8,572 Revelation Biosciences Warrant shares in Q2 2026, an estimated $89.
Revelation Biosciences Warrant made up ﹤0.01% of Pine Valley Investments's portfolio in Q2 2026, its #609 holding.
Pine Valley Investments first reported a position in Revelation Biosciences Warrant in Q1 2023 and has held it in 14 quarters since.
Pine Valley Investments's Revelation Biosciences Warrant position peaked at $4.22K in Q3 2023.
4 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.